News Corner

Our site uses cookies to make navigation as function as possible, including “third party” cookies and “profiling cookies” designed to tailor
on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your
consent to some or all cookies, click here. If you proceed with browsing this website, you will be consenting to the use of all cookies.

News Corner

2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011

2023

Menarini presents in Florence its latest art monograph, dedicated to the symbol of the Italian Renaissance.May 16 2023
The Dates of the XXVII Edition of the International Fair Play Menarini AwardsApril 13 2023
Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast CancerJanuary 30 2023

2022

2021

2020

2019

Tillotts partners Menarini to extend Asacol® to the People_s Republic of ChinaNovember 08 2019
MENARINI: ELCIN BARKER ERGUN GROUP CEOSeptember 12 2019
Dermatix(R) Unveils New Product Breakthrough for Acne Scarring SolutionJuly 23 2019
CALECIM® partners Menarini Asia-Pacific to expand reach of its stem cell skin care products in the regionMay 01 2019

2018

Art in a Click: Menarini Launches "Pills of Art"November 07 2018
Two-thirds of Australians surveyed affected by mild anxiety¹October 16 2018
Menarini and Orion Sign Regional Partnerships in Asia-PacificJuly 03 2018
Daiichi Sankyo and Menarini Enter into Exclusive Licensing Agreement for Commercializing LIXIANA® in the Philippines, Malaysia and SingaporeJune 29 2018
Menarini Announces New GovernanceMarch 22 2018
Menarini Hires Their 17,000th EmployeeMarch 12 2018

2017

Carabinieri's CSI Department Has New Technology For Fighting CrimeSeptember 28 2017
COPD Increasing an Open Dialogue Between Patients and PhysiciansSeptember 11 2017
Selvita And Menarini Group announce Global License Agreement for Clinical Stage Oncology Drug PimFlt3 Inhibitor Sel24March 28 2017
Menarini arrives in Columbia and PeruMarch 13 2017
Melinta Therapeutics and Menarini Group Enter into Commercial and Co-Development Agreement for Delafloxacin in 68 CountriesMarch 03 2017
Menarini in Turkey: + 25% Growth in 2016 and New Headquarters in IstanbulJanuary 19 2017

2016

2015

4SC Signs Licensing and Development Agreement with Menarini for Resminostat in Asia-Pacific Excluding JapanApril 16 2015

2014

The Menarini Group New Molecule Against Lymphomas And Solid TumorsNovember 25 2014
Menarini One of the Top Ten Most Patient Friendly CompaniesJune 20 2014
Three Visiting Experts Urge Women to Get Their Partners Treated for Premature EjaculationMarch 07 2014
Moberg Pharma and Menarini Extend Distribution Agreement for Kersal Nail to South East AsiaFebruary 14 2014

2013

2012

2011

Menarini Group Succeeds in Bid for Invida GroupNovember 15 2011
Invida Announces Acquisition of Dermatology and Primary Care Product Portfolios in IndiaNovember 14 2011
Singapore-based Invida Announces Expansion of Dermatology Portfolio Ahead of World Congress of Dermatology 2011May 24 2011
Invida to Present at the BioCentury Future Leaders in the Biotech Industry ConferenceApril 11 2011
Sinclair Pharma and Invida Group agree partnership deal for the commercialisation of Sinclair's leading brands in IndiaMarch 21 2011
Invida Forms Unique Partnership With Roche In KoreaFebruary 16 2011
Orexo and Invida Jointly Announce Agreement for Abstral in Asia-PacificJanuary 15 2011

If you'd like to know more about Menarini, feel free to download our PDF files here.

FONDAZIONE MENARINI

A non-profit institution founded in 1976 to promote research...

MENARINI IN ASIA-PACIFIC

Find our companies

within Asia-Pacific:

FEATURED

FEATURED ARTICLE

Daiichi Sankyo and Menarini Enter into Exclusive Licensing Agreement for Commercializing LIXIANA® in the Philippines, Malaysia and Singapore